CN112868871A - Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof - Google Patents
Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof Download PDFInfo
- Publication number
- CN112868871A CN112868871A CN202110228447.4A CN202110228447A CN112868871A CN 112868871 A CN112868871 A CN 112868871A CN 202110228447 A CN202110228447 A CN 202110228447A CN 112868871 A CN112868871 A CN 112868871A
- Authority
- CN
- China
- Prior art keywords
- powder
- tea
- parts
- fatigue
- radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 39
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 29
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 28
- 230000003471 anti-radiation Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 106
- 235000013616 tea Nutrition 0.000 claims abstract description 72
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 36
- 235000009569 green tea Nutrition 0.000 claims abstract description 34
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 18
- 239000011718 vitamin C Substances 0.000 claims abstract description 18
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 14
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 12
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 12
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000600 sorbitol Substances 0.000 claims abstract description 12
- 235000010356 sorbitol Nutrition 0.000 claims abstract description 12
- 229940013618 stevioside Drugs 0.000 claims abstract description 12
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000019202 steviosides Nutrition 0.000 claims abstract description 12
- 239000000811 xylitol Substances 0.000 claims abstract description 12
- 235000010447 xylitol Nutrition 0.000 claims abstract description 12
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 12
- 229960002675 xylitol Drugs 0.000 claims abstract description 12
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 11
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 11
- 239000004376 Sucralose Substances 0.000 claims abstract description 11
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 11
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 11
- 229960004853 betadex Drugs 0.000 claims abstract description 11
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 11
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 11
- 235000019408 sucralose Nutrition 0.000 claims abstract description 11
- 230000005855 radiation Effects 0.000 claims abstract description 7
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 5
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 5
- 150000004676 glycans Chemical class 0.000 claims abstract description 5
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 5
- 239000005017 polysaccharide Substances 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 62
- 239000002245 particle Substances 0.000 claims description 25
- 238000002156 mixing Methods 0.000 claims description 21
- 239000008187 granular material Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 239000011812 mixed powder Substances 0.000 claims description 12
- 239000007779 soft material Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 6
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 2
- 244000166124 Eucalyptus globulus Species 0.000 claims 1
- 244000178231 Rosmarinus officinalis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 235000009508 confectionery Nutrition 0.000 abstract description 7
- 230000000052 comparative effect Effects 0.000 description 14
- 229920002527 Glycogen Polymers 0.000 description 13
- 229940096919 glycogen Drugs 0.000 description 13
- 230000009182 swimming Effects 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 10
- 244000004281 Eucalyptus maculata Species 0.000 description 8
- 241000862336 Poliomintha Species 0.000 description 8
- 235000017716 Poliomintha incana Nutrition 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000010254 Jasminum officinale Nutrition 0.000 description 6
- 240000005385 Jasminum sambac Species 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 235000020733 paullinia cupana extract Nutrition 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 235000007516 Chrysanthemum Nutrition 0.000 description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 230000005484 gravity Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021539 instant coffee Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000009475 tablet pressing Methods 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of candies, and particularly discloses a radiation-resistant and fatigue-resistant tea buccal tablet which comprises the following raw materials in parts by weight: 20-30 parts of sorbitol, 20-30 parts of xylitol, 20-40 parts of green tea, 1-2 parts of tea polysaccharide, 0.5-1.5 parts of yeast beta-glucan, 0.5-1.5 parts of magnesium stearate, 0.3-1 part of vitamin C, 0.5-1.0 part of stevioside, 0.1-0.3 part of sucralose, 0.5-1 part of DL-malic acid and 1-2 parts of beta-cyclodextrin; the green tea is low mountain summer tea and/or low mountain autumn tea with elevation of 600-800m in Chongqing city. The invention also discloses a preparation method of the anti-radiation and anti-fatigue tea buccal tablet. The anti-radiation anti-fatigue tea buccal tablet provided by the invention has an obvious anti-fatigue effect.
Description
Technical Field
The invention belongs to the technical field of candies, and particularly relates to an anti-radiation anti-fatigue tea buccal tablet and a preparation method thereof.
Background
The tea has the functions of promoting human excitement, benefiting intelligence, eliminating fatigue, reducing blood fat and blood pressure, resisting radiation and the like, and is one of the accepted health drinks in the world. The working pressure of the current society learning is large, the fatigue feeling is not avoided, and some important occasions (such as driving, overtime, standby examination and the like) need to eat anti-fatigue products with convenient and fast eating and more obvious effect. With the intensive study of the health-care function of tea, together with the increase in the above-mentioned pressure, the consumption of tea is rapidly increasing.
Aiming at the anti-fatigue product, the Chinese invention patent application with the application publication number of CN109588524A discloses an qi-tonifying, refreshing and anti-fatigue tabletted candy, which comprises the following raw materials in parts by weight: 5-15% of green tea powder, 5-15% of instant coffee powder, 5-10% of fermented ginseng powder, 0.4-0.8% of menthol, 25-35% of soybean milk powder, 0.5-2% of vitamin C, 25-35% of non-dairy creamer, 0.4-0.8% of stevioside, 5-15% of D-mannitol, 15-30% of maltodextrin and 1-2% of magnesium stearate. The preparation method comprises weighing the above materials in proportion, mixing, pulverizing, sieving, soaking in ethanol, granulating, drying, grading, and tabletting.
The tabletted candy provided by the patent is high in cost, and long-term eating of the tabletted candy can cause the eater to be confused and anxious due to the addition of a large amount of instant coffee powder. In addition, the above patent contains many tonic components, and too many tonic components may burden the liver.
Disclosure of Invention
The invention aims to provide a radiation-resistant and fatigue-resistant tea buccal tablet which has a remarkable fatigue-resistant effect and does not increase the tension and anxiety of eaters, and a preparation method thereof.
In order to achieve the purpose, the technical scheme of the invention is as follows:
the anti-radiation and anti-fatigue tea buccal tablet comprises the following raw materials in parts by weight: 20-30 parts of sorbitol, 20-30 parts of xylitol, 20-40 parts of green tea, 3-5 parts of rosemary mint eucalyptus leaf supercritical extraction mixture, 8-10 parts of guarana extract, 1-2 parts of tea polysaccharide, 0.5-1.5 parts of yeast beta-glucan, 0.5-1.5 parts of magnesium stearate, 0.3-1 part of vitamin C, 0.5-1.0 part of stevioside, 0.1-0.3 part of sucralose, 0.5-1 part of DL-malic acid and 1-2 parts of beta-cyclodextrin; the green tea is low mountain summer tea and/or low mountain autumn tea with elevation of 600-800m in Chongqing city.
The invention also discloses a preparation method of the anti-radiation and anti-fatigue tea buccal tablet, which comprises the following steps,
s1, crushing:
crushing green tea to 800 meshes and 1000 meshes to obtain green tea powder;
crushing and sieving the raw materials with the particle size of more than 178 mu m to respectively obtain sorbitol powder, xylitol powder, magnesium stearate powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder;
the raw materials with the particle size less than or equal to 178 mu m can be sieved without being crushed;
s2, primary mixing: mixing the green tea powder obtained in the step S1, sorbitol powder, xylitol powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder, and uniformly mixing to obtain mixed powder;
s3, soft material preparation: stirring the mixed powder obtained in the step S2, slowly spraying a wetting agent into the mixed powder to increase the humidity of the material, and preparing a soft material, wherein the amount of the wetting agent is that the mixed powder can be kneaded into a mass by hands, and the mass can be dispersed by pressing with fingers;
s4, granulating: adding the soft material obtained in the step S3 into a hopper, and preparing wet particles with uniform size and proper looseness;
s5, drying: transferring the wet granules prepared in S4 into a dryer, drying at 45-55 deg.C for 45-70min to obtain dried granules with water content below 3-5%;
s6, finishing the grains: granulating the dried granules obtained in S5;
s7, secondary mixing: adding the magnesium stearate powder obtained in the step S1 into the whole particles, and uniformly mixing to obtain total mixed particles;
s8, tabletting: and (5) tabletting the total mixed particles obtained in the step (S7) under the condition that the humidity is less than or equal to 40% to obtain the buccal tablets.
The principle and the beneficial effects of the technical scheme are as follows:
(1) with the increasing attention of people to the self health, the candies with the health care function are more and more popular, the technical scheme combines the health care function of tea leaves and the advantages of good palatability and convenient eating of the buccal tablets, and the buccal tablets with remarkable anti-fatigue effect are prepared by adopting raw materials of sorbitol, xylitol, green tea, magnesium stearate and the like in a specific proportion.
(2) The tea buccal tablet has the advantages that the taste of the tea buccal tablet is bitter due to the fact that the tea is not dissolved in the mouth due to the fact that the tea is added in a large amount, and the taste of the whole tea buccal tablet is affected due to the fact that the tea is added in a large amount, so that the tea buccal tablet in the prior art cannot be added with excessive tea, and the anti-fatigue and refreshing effects are enhanced by frequently adding coffee (such as CN 109588524A).
The green tea in the technical scheme has high addition amount, and during preparation, the green tea is crushed to 800-mesh and 1000-mesh at the temperature of 20-40 ℃, so that the obtained green tea powder is fine and smooth, the taste is ensured, meanwhile, the effective components such as tea polyphenol, caffeine, vitamin C and the like are retained to the maximum extent, and the anti-fatigue effect of the whole buccal tablet is ensured.
In addition, in the technical scheme, stevioside and sucralose are compounded to be used as a sweetening agent, so that the bitter taste of green tea can be effectively masked; DL-malic acid has sour taste, and can improve the taste of the whole buccal tablet; the beta-cyclodextrin can effectively embed the bitter taste of the green tea.
Sorbitol and xylitol mainly play a technical role in seasoning and bonding, and magnesium stearate plays a technical role in glidants.
(3) The Chongqing city is located in the south of Daba mountain, the climate is mild, the rainfall is abundant, the sunshine is sufficient, the surface water system is developed, the soil is rich in essential microelements such as selenium, zinc, chromium, manganese and the like for human bodies, and the obtained low mountain summer tea with the altitude of 600-800m has a good anti-fatigue effect and a good anti-radiation and anti-oxidation effect.
With the quality good, sell good spring tea and compare, the quality of summer tea, the taste is relatively poor, sell less, the quality of autumn tea, the taste is the worst, can not sell almost, but summer tea and autumn tea must be picked, otherwise can influence the spring tea of next year and sprout, this technical scheme chooses for use Chongqing city mouth elevation 600 to add one's shoulder or back the spring tea of height 800m, can effectively improve the utilization ratio of low mountain summer tea and low mountain autumn tea, promote the added value of tealeaves industry, reduce the manufacturing cost of whole buccal tablet.
(4) The total amount of the vitamin C contained in the green tea and the vitamin C added as the raw material again can meet the requirement of GB28050-2011 on vitamin C-rich products.
(5) S5, the air inlet temperature is controlled to be 45-55 ℃, drying is carried out for 45-70min, and the air inlet temperature is higher than 55 ℃ or the drying time is higher than 70min, so that dry particles are cracked, and effective components (such as vitamin C) sensitive to temperature are lost; the air inlet temperature is less than 45 ℃ or the drying time is less than 45min, which can cause insufficient drying of the dried particles. S8, tabletting is carried out under the condition that the humidity is less than or equal to 40% in order to prevent the total mixed particles from sticking and ensuring the surface integrity of the obtained buccal tablet.
(6) The green tea, the tea polysaccharide and the yeast beta-glucan in the technical scheme play a role together, so that the radiation resistance effect of the whole buccal tablet is ensured.
Preferably, the rosemary mint eucalyptus supercritical extraction liquid also comprises 3-5 parts of rosemary mint eucalyptus leaf supercritical extraction mixture. The technical scheme can effectively improve the anti-fatigue effect of the whole buccal tablet.
Preferably, the edible essence also comprises 1-2 parts of edible essence, wherein the edible essence comprises one or a mixture of more than two of mint essence, green tea essence or milk essence. The technical scheme can effectively improve the taste of the whole buccal tablet.
Preferably, the jasmine flower tea also comprises 1.5-2 parts of jasmine flower. Jasmine is effective in masking the bitter taste of tea leaves and improving lethargy and anxiety.
Preferably, 0.5 to 1.2 parts of chrysanthemum is also included. The technical scheme can further effectively improve the taste of the whole lozenge, cover the bitter taste of tea, improve the appearance and increase the purchasing power of the whole anti-radiation and anti-fatigue tea lozenge.
Preferably, the mixing time of S2 and S7 is 10min or more. The technical scheme can ensure the full mixing of S2 and S7.
Drawings
FIG. 1 is a flow chart of example 1 of the present invention.
Detailed Description
The following is further detailed by way of specific embodiments:
green tea screening
The screening of green tea is specifically shown in table 1 below. The zinc in table 1 was detected with reference to GB 5009.14-2017; detecting selenium according to GB 5009.93-2017; vitamin B2 was tested with reference to GB 5009.85-2016; detecting vitamin C with reference to GB 5009.86-2016; detecting tea polyphenol with reference to GB/T8313-2018; detecting caffeine with reference to GB/T8312-2013; glutamic acid is detected by referring to reference document HPLC-PITC derivation method for determining amino acid content of Xinjiang grapevine bleeding sap; theanine was detected with reference to GB/T23193-2017.
The low altitude range in Table 1 is 600m or less and the low altitude is 800m or less; the range of the middle altitude is more than 800m and less than 1000 m; the range of the high altitude is more than or equal to 1000m and the high altitude is less than or equal to 1200 m.
TABLE 1 Green tea Screen
As can be seen from table 1 above: the low mountain summer tea and the low mountain autumn tea both contain higher content of vitamin C and caffeine.
The buccal tablets with excellent efficacy can be prepared by selecting one or a mixture of more than two of low-mountain spring tea, high-mountain spring tea, low-mountain summer tea or low-mountain autumn tea, daily production can be selected according to the functions of the buccal tablets, but in order to prepare the anti-radiation and anti-fatigue lozenge, the taste of the low-mountain summer tea and the low-mountain autumn tea is not good and the lozenge cannot be sold generally in consideration of price, and the following embodiments adopt the low-mountain summer tea and/or the low-mountain autumn tea.
Second, example 1
The embodiment provides a radiation-resistant and fatigue-resistant tea buccal tablet which comprises the following raw materials in parts by weight: 20 parts of sorbitol, 20 parts of xylitol, 20 parts of green tea, 1 part of tea polysaccharide, 0.5 part of yeast beta-glucan, 0.5 part of magnesium stearate, 0.3 part of vitamin C, 0.5 part of stevioside, 0.1 part of sucralose, 0.5 part of DL-malic acid, 1 part of beta-cyclodextrin and 1 part of edible essence, wherein the edible essence comprises a mixture (1:1:1) of mint essence, green tea essence and milk essence.
The green tea used in this example was prepared by mixing 1 part by weight: 1 low mountain summer tea and low mountain autumn tea.
As shown in fig. 1, this embodiment further provides a method for preparing the above lozenge of tea with anti-radiation and anti-fatigue effects, which comprises the following steps,
s1, crushing:
firstly, grinding green tea to 800-1000 meshes by an airflow grinder at the temperature of 20-40 ℃, wherein the grinding time is more than or equal to 10min to obtain green tea powder; when the green tea is ground to 900 meshes and the grinding time is 15min, the obtained green tea powder is fine and smooth and has the best taste.
Secondly, respectively sieving the raw materials with the particle size of more than 178 mu m through a sieve of 80 meshes to respectively obtain sorbitol powder, xylitol powder, magnesium stearate powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder; the screen is required to be clean, and different stainless steel spoons, screens or stainless steel barrels are used for different raw materials.
The raw material with the grain size less than or equal to 178 mu m can be purchased without passing through a 80-mesh sieve.
S2, primary mixing: and (2) pouring the green tea powder obtained in the step (S1), sorbitol powder, xylitol powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder into a mixing machine for mixing for more than or equal to 15min, and uniformly mixing to obtain mixed powder.
S3, soft material preparation: after the materials are mixed evenly, a wetting agent (50-75% ethanol solution) is slowly sprayed into the mixed powder by a small spray can while stirring to increase the humidity of the materials, and the materials are prepared into soft materials, wherein the addition amount of the wetting agent is that the mixed powder can be kneaded into balls by hands, and the materials can be dispersed by pressing with fingers. When the humectant is 75% ethanol, the texture of the resulting mixed powder is optimal.
S4, granulating: a clean 16-mesh screen was placed flush into a rocking granulator, and the soft material from S3 was added to the hopper to adjust the nylon mesh tightness depending on the granulate produced. Making into wet granule with uniform size and suitable loosening.
S5, drying: transferring the wet granules obtained in S4 into a dryer, drying at 45-55 deg.C for 45-70min to obtain dry granules with water content below 3-5%. The air inlet temperature is preferably 51 ℃ in the implementation, and the dried particles obtained by drying for 54min have the best appearance.
S6, finishing the grains: and (4) transferring the dried particles obtained in the step (S5) to an 18-mesh rotary vibrating screen by using a stainless steel scoop for grading, respectively collecting upper-layer large particles and lower-layer particles of the rotary vibrating screen, processing the large particles, then screening the processed large particles by using the 18-mesh rotary vibrating screen, and combining the processed large particles with the lower-layer particles.
S7, secondary mixing: and (4) adding the magnesium stearate powder obtained in the step (S1) into the whole granules, and uniformly mixing the magnesium stearate powder and the whole granules for more than or equal to 10min to obtain the total mixed granules.
S8, tabletting: and (5) tabletting the total mixed particles obtained in the step (S7) under the condition that the humidity is less than or equal to 40% to obtain the buccal tablets.
Adjusting the filling amount of the tablet press to 0.6g of tablet weight, controlling the tablet pressing pressure to ensure that the tablet hardness is about 50N, and tabletting to obtain plain tablets, wherein the tablet weight difference is controlled to be +/-5%. The room humidity should be controlled between 30-40% during tabletting.
S10, inner packaging: and (4) taking the inner packaging bag qualified by quality inspection, and carrying out inner packaging according to the planned packaging amount.
S11, outer packaging: and (5) externally packaging the materials subjected to the internal packaging.
S11, warehousing: after the product is qualified, the product is sealed and packed into a qualified product warehouse (area) and the warehousing procedure is handled.
Third, examples 2 to 6
Examples 2-6 differ from example 1 only in the amount of starting material, and the specific starting materials for examples 2-6 are shown in table 3 below:
table 3 examples 1-6
Fourthly, examples 7 to 12
Examples 7-12 differ from example 5 only in that: examples 7-9 further include 3-5 parts of a supercritical rosemary mint eucalyptus leaf extract mixture; the supercritical extraction mixture of rosemary mint eucalyptus leaves is prepared by the following method: weighing herba Rosmarini officinalis, herba Menthae and folium Eucalypti Globueli at a ratio of 2:1:1, pulverizing to 40-80 mesh, adding into extraction kettle, soaking for 1.5-3 hr under 18-30MPa, and supercritical CO2Extracting for 2-4h with an extractor at 35-55 deg.C with CO2The flow rate is 10 L.h-1And collecting the supercritical extraction mixture after extraction is finished.
Examples 10-12 also include guarana extract 5-10 parts.
The differences between examples 7 to 12 and example 5 are specifically seen in table 4 below:
TABLE 4 differences between example 5 and examples 7 to 12
Fifth, examples 13 to 18
Examples 13-18 differ from example 12 only in that: examples 13-15 also include 1.5-2 parts of jasmine, examples 16-18 also include 0.5-1.2 parts of chrysanthemum, and the differences between examples 13-18 and example 12 are specifically seen in table 4 below:
TABLE 4 differences between example 12 and examples 13 to 18
Sixth, examples 19 to 21
Examples 19-21 differ from example 18 only in that: the weight ratio of the low mountain summer tea to the low mountain autumn tea is different, and the differences of the examples 19 to 21 from the example 18 are shown in the following table 5:
TABLE 5 differences between example 12 and examples 19 to 21
Seventh, comparative examples 1 to 3
Comparative example 1 an qi-invigorating and refreshing tabletted candy was prepared using the chinese patent application with application publication No. CN 109588524A.
Comparative example 2 differs from example 12 only as shown in table 6 below:
TABLE 6 difference between comparative example 2 and example 12
Comparative example 3 differs from example 18 only as shown in table 7 below:
TABLE 7 difference between comparative example 3 and example 18
Eighthly, experiment of exhaustion of swimming under load, experiment of hepatic glycogen and muscular glycogen
SD rats weighing 200-. After feeding for two weeks, the mice were placed in a swimming box at 30 ℃ with a 5% weight lead skin on the tail and root, and the time from the beginning of swimming to the time when the head of the mouse could not float out of the water surface for more than eight seconds was recorded by a stopwatch as the time for exhaustion of swimming, and the specific experimental results are shown in the following tables 8-11.
In addition, SD rats weighing 200-250g were divided into 25 groups, namely, experimental groups 1-21, comparative groups 1-3 and blank groups, each group containing 5 animals and females, and the experimental groups 1-21 and comparative groups 1-3 were fed with the buccal tablets of tea leaves prepared in examples 1-21 and comparative example 1, respectively, and the blank group was not fed with the buccal tablets. Two weeks after feeding, mice were recorded for liver glycogen and muscle glycogen as shown in tables 8-11 below.
TABLE 8 negative gravity swimming exhaust time, liver glycogen and muscle glycogen of experimental groups 1-6, comparative group 1 and blank group
Note: p was < 0.05 compared to the blank control.
And (3) knotting: in experimental groups 1 to 6, the mice in experimental group 5 had longer negative gravity swimming time and the content of glycogen and myoglycogen increased significantly, which indicates that the tea buccal tablets prepared in example 5 had better anti-fatigue effect.
TABLE 9 negative gravity exhaust swimming time, liver glycogen and muscle glycogen of Experimental groups 7-12 and comparative group 2
Note: p was < 0.05 compared to the blank control.
And (3) knotting:
(1) compared with the embodiment 5, the swimming time of the embodiment 7-9 added with the rosemary mint eucalyptus leaf supercritical extraction mixture is improved by 21.31-28.82%; compared with example 5, the anti-fatigue effect of example 12, which added both rosemary mint eucalyptus leaf supercritical extract mixture and guarana extract, was better.
(2) Compared with example 5, the swimming time of comparative example 2 added with the guarana extract is only improved by 20.73%, which shows that the addition of the rosemary mint eucalyptus leaf supercritical extraction mixture and the guarana extract can play a synergistic effect, and the anti-fatigue effect of the whole buccal tablet is obviously improved.
TABLE 10 negative gravity exhaust swimming time, liver glycogen and muscle glycogen of Experimental group 13-18 and comparative group 3
Note: p was < 0.05 compared to the blank control.
And (3) knotting: compared with the embodiment 12 and the comparative example 3, the embodiment 18 with the jasmine flower and the chrysanthemum added simultaneously has the advantage that the anti-fatigue effect is obviously improved, which shows that the jasmine flower and the chrysanthemum added can have a synergistic effect and the anti-fatigue effect of the whole buccal tablet is obviously improved.
TABLE 11 weight-depleted swimming times, liver glycogen and muscle glycogen of examples 19-21
Note: p was < 0.05 compared to the blank control.
And (3) knotting: in comparison between examples 18 and 21, it can be seen that the anti-fatigue effect of the whole buccal tablet is better when the weight ratio of the low mountain summer tea to the low mountain autumn tea is 1: 0.5.
The foregoing detailed description of the preferred embodiments of the invention has been presented. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.
Claims (5)
1. The anti-radiation and anti-fatigue tea buccal tablet is characterized by comprising the following raw materials in parts by weight: the feed comprises the following raw materials in parts by weight: 20-30 parts of sorbitol, 20-30 parts of xylitol, 20-40 parts of green tea, 1-2 parts of tea polysaccharide, 0.5-1.5 parts of yeast beta-glucan, 0.5-1.5 parts of magnesium stearate, 0.3-1 part of vitamin C, 0.5-1.0 part of stevioside, 0.1-0.3 part of sucralose, 0.5-1 part of DL-malic acid and 1-2 parts of beta-cyclodextrin; the green tea is low mountain summer tea and/or low mountain autumn tea with elevation of 600-800m in Chongqing city.
2. The buccal tablet of radiation-resistant and fatigue-resistant tea as claimed in claim 1, further comprising 3-5 parts of a supercritical extraction mixture of rosemary, mint and eucalyptus leaves.
3. The radiation-resistant fatigue-resistant tea buccal tablet according to claim 1 or 2, which further comprises 1-2 parts of edible essence, wherein the edible essence comprises one or a mixture of more than two of mint essence, green tea essence or milk essence.
4. The preparation method of the anti-radiation and anti-fatigue tea buccal tablet according to claim 1, which comprises the following steps,
s1, crushing:
firstly, crushing green tea to 800-1000 meshes at 20-40 ℃ to obtain green tea powder;
crushing and sieving the raw materials with the particle size of more than 178 mu m to respectively obtain sorbitol powder, xylitol powder, magnesium stearate powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder;
the raw materials with the particle size less than or equal to 178 mu m can be sieved without being crushed;
s2, primary mixing: mixing the green tea powder obtained in the step S1, sorbitol powder, xylitol powder, vitamin C powder, stevioside powder, sucralose powder, DL-malic acid powder and beta-cyclodextrin powder, and uniformly mixing to obtain mixed powder;
s3, soft material preparation: stirring the mixed powder obtained in the step S2, slowly spraying a wetting agent into the mixed powder to increase the humidity of the material, and preparing a soft material, wherein the amount of the wetting agent is that the mixed powder can be kneaded into a mass by hands, and the mass can be dispersed by pressing with fingers;
s4, granulating: adding the soft material obtained in the step S3 into a hopper, and preparing wet particles with uniform size and proper looseness;
s5, drying: transferring the wet granules prepared in S4 into a dryer, drying at 45-55 deg.C for 45-70min to obtain dried granules with water content below 3-5%;
s6, finishing the grains: granulating the dried granules obtained in S5;
s7, secondary mixing: adding the magnesium stearate powder obtained in the step S1 into the whole particles, and uniformly mixing to obtain total mixed particles;
s8, tabletting: and (5) tabletting the total mixed particles obtained in the step (S7) under the condition that the humidity is less than or equal to 40% to obtain the buccal tablets.
5. The preparation method of the anti-radiation and anti-fatigue tea buccal tablet according to claim 4, wherein the mixing time of S2 and S7 is not less than 10 min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110228447.4A CN112868871A (en) | 2021-03-02 | 2021-03-02 | Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110228447.4A CN112868871A (en) | 2021-03-02 | 2021-03-02 | Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112868871A true CN112868871A (en) | 2021-06-01 |
Family
ID=76055170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110228447.4A Pending CN112868871A (en) | 2021-03-02 | 2021-03-02 | Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112868871A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723787A (en) * | 2005-07-18 | 2006-01-25 | 朱由康 | Chewing and eating type tea leaves pellets, and its prepn. method |
| CN1907061A (en) * | 2006-08-02 | 2007-02-07 | 吉林华康药业股份有限公司 | Health food capable of resisting fatigue |
| CN108523130A (en) * | 2018-07-20 | 2018-09-14 | 河南姜生堂生物科技有限公司 | A kind of antifatigue buccal tablet and preparation method thereof containing ginger oil |
| CN109007714A (en) * | 2018-06-07 | 2018-12-18 | 广东方制药有限公司 | A kind of peppermint flavor jelly and preparation method thereof |
| CN109077237A (en) * | 2018-10-26 | 2018-12-25 | 重庆市三品功能食品研究院有限公司 | A kind of vermicelli and preparation method thereof that suitable hyperglycemia population is edible |
| CN209693935U (en) * | 2018-09-30 | 2019-11-29 | 东源福群生态农业开发有限公司 | A kind of multilayered structure green tea lozenge |
| CN111937999A (en) * | 2020-09-11 | 2020-11-17 | 洛阳师范学院 | Green tea coffee lozenge and preparation method thereof |
-
2021
- 2021-03-02 CN CN202110228447.4A patent/CN112868871A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1723787A (en) * | 2005-07-18 | 2006-01-25 | 朱由康 | Chewing and eating type tea leaves pellets, and its prepn. method |
| CN1907061A (en) * | 2006-08-02 | 2007-02-07 | 吉林华康药业股份有限公司 | Health food capable of resisting fatigue |
| CN109007714A (en) * | 2018-06-07 | 2018-12-18 | 广东方制药有限公司 | A kind of peppermint flavor jelly and preparation method thereof |
| CN108523130A (en) * | 2018-07-20 | 2018-09-14 | 河南姜生堂生物科技有限公司 | A kind of antifatigue buccal tablet and preparation method thereof containing ginger oil |
| CN209693935U (en) * | 2018-09-30 | 2019-11-29 | 东源福群生态农业开发有限公司 | A kind of multilayered structure green tea lozenge |
| CN109077237A (en) * | 2018-10-26 | 2018-12-25 | 重庆市三品功能食品研究院有限公司 | A kind of vermicelli and preparation method thereof that suitable hyperglycemia population is edible |
| CN111937999A (en) * | 2020-09-11 | 2020-11-17 | 洛阳师范学院 | Green tea coffee lozenge and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 慎乐菱: "老中医减肥茶 6道茶饮帮你边喝变瘦", 《养生频道》 * |
| 沈国;叶田;周洋;扈晓佳: "瓜拉纳提取物的功能性研究进展" * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103005431B (en) | Seedless roxburgh rose-angelica keiskei composite chewable tablet and preparation method thereof | |
| CN103652092B (en) | Maca tea oral tablet and preparation method thereof | |
| CN103168887A (en) | Method for preparing maca tea bag | |
| CN108125004A (en) | A kind of double mountain Siberian cocklebur heart of a lotus seed tea | |
| CN104473008A (en) | Xeransis selenium-enriched red bean and coix seed powder and preparation method thereof | |
| CN102907745A (en) | Solid beverage for clearing liver and decreasing lipid and preparation method of solid beverage | |
| CN102754724A (en) | Granular ganoderma lucidum substitution tea and preparation method thereof | |
| CN104738450A (en) | Preparation method of stem-free acanthopanax gracilistylus fruit powder and effervescent tablets of stem-free acanthopanax gracilistylus fruit powder | |
| CN105639652B (en) | Cortex Eucommiae blueberry composite chewable tablet and preparation method thereof | |
| CN101579125B (en) | Soybean milk powder rich in dietary fiber, vitamins, calcium, iron, zinc and selenium | |
| JPH0838124A (en) | Medicinal herb tea containing longanae arillus and production thereof | |
| CN103431328B (en) | Natural jackfruit powder and preparation method thereof | |
| CN110025730B (en) | Dendrobium huoshanense buccal tablets and preparation method thereof | |
| KR100840639B1 (en) | Tea which tangerine peel is used as main materials and its manufacturing method | |
| CN108552440B (en) | Coix seed and red bean fruit particle beverage and preparation method thereof | |
| CN112868871A (en) | Anti-radiation anti-fatigue tea buccal tablet and preparation method thereof | |
| CN104489844A (en) | Barley solid beverage and preparation method thereof | |
| CN1048854C (en) | Compound bagged glossy ganoderma tea | |
| CN107691959A (en) | A kind of lucidum spore powder effervescent tablet and preparation method thereof | |
| CN103931835A (en) | Preparation of granular stanuntonia chinensis tea | |
| CN104336215A (en) | Green tea powder, preparation method and application thereof | |
| CN106722058B (en) | Instant dampness-eliminating cereal piece/powder and preparation method thereof | |
| CN105166619A (en) | Red bean flavor honey powder for maintaining beauty and keeping young and preparation method thereof | |
| CN110063452A (en) | A kind of compound instant brewed powder of millet and preparation method thereof | |
| CN104186757A (en) | Health green tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210601 |